LGMD2I presenting with a characteristic Duchenne or Becker muscular dystrophy phenotype.
about
LGMD2I in a North American populationHomozygous nonsense mutation in SGCA is a common cause of limb-girdle muscular dystrophy in Assiut, Egypt.Calpain 3 is important for muscle regeneration: evidence from patients with limb girdle muscular dystrophies.Level of muscle regeneration in limb-girdle muscular dystrophy type 2I relates to genotype and clinical severity.Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): case definition in surveillance for childhood-onset Duchenne/Becker muscular dystrophy.Neo-epitope Peptides as Biomarkers of Disease Progression for Muscular Dystrophies and Other Myopathies.Dose-dependent restoration of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered morpholino.Limb-girdle muscular dystrophy type 2I: two Chinese families and a review in Asian patients.A heterozygous 21-bp deletion in CAPN3 causes dominantly inherited limb girdle muscular dystrophy.cDNA analyses of CAPN3 enhance mutation detection and reveal a low prevalence of LGMD2A patients in Denmark.Contractile properties are disrupted in Becker muscular dystrophy, but not in limb girdle type 2I.Clinical Utility Gene Card for: Becker muscular dystrophy.Immunodetection analysis of muscular dystrophies in Mexico.Magnetic Resonance Imaging Findings in the Muscle Tissue of Patients with Limb Girdle Muscular Dystrophy Type 2I Harboring the Founder Mutation c.545A>G in the FKRP Gene.Clinical and muscle biopsy findings in Norwegian paediatric patients with limb girdle muscular dystrophy 2I
P2860
Q33307069-805D844B-42C6-4C1F-B800-3AF94A6B34ACQ33751724-1418C667-017D-4186-823B-7AFF7C1D1112Q34207404-C344D94E-39FC-42A1-9FA2-867C3D2BA1D8Q35398252-DF3ACC6C-D6CA-4AB8-8B1B-62161FCF5E18Q36907553-6839FE10-8660-4F7C-A7D0-B3BA44AB2CB8Q42363358-EE98F729-DC89-4075-BC8C-7D0CBFBF5A85Q43275640-F1A1F967-3DC6-451A-AF56-EE4A14FFD29BQ47767530-7FE2D5AC-F6C4-44F3-B41B-0FCCB533381AQ48695686-5B6F4C9A-3C72-4B67-81B5-62CE00BFF07AQ50547039-FD6391A3-4A36-45AF-B590-E34D619AC56CQ52673776-70561FA6-85E6-4743-A893-AC489F740909Q54269189-3CDE5575-0E02-43AF-9572-98F7B5EA14DFQ54529815-9BF94C77-94C4-4E81-982C-74CD48C63EBDQ55555004-67333453-C92D-46B0-8225-7EC8BDBB024EQ57642759-BD800C9B-3AA3-4FF7-9631-E11E456FFFEE
P2860
LGMD2I presenting with a characteristic Duchenne or Becker muscular dystrophy phenotype.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
LGMD2I presenting with a characteristic Duchenne or Becker muscular dystrophy phenotype.
@en
LGMD2I presenting with a characteristic Duchenne or Becker muscular dystrophy phenotype.
@nl
type
label
LGMD2I presenting with a characteristic Duchenne or Becker muscular dystrophy phenotype.
@en
LGMD2I presenting with a characteristic Duchenne or Becker muscular dystrophy phenotype.
@nl
prefLabel
LGMD2I presenting with a characteristic Duchenne or Becker muscular dystrophy phenotype.
@en
LGMD2I presenting with a characteristic Duchenne or Becker muscular dystrophy phenotype.
@nl
P2093
P1433
P1476
LGMD2I presenting with a characteristic Duchenne or Becker muscular dystrophy phenotype
@en
P2093
John Vissing
Marianne Schwartz
Marie Louise Sveen
P304
P356
10.1212/01.WNL.0000157654.59374.E5
P407
P50
P577
2005-05-01T00:00:00Z